Nichd best pharmaceuticals for children act - pediatric trials network (bpca-PTN) 2018-2026

Ended Indefinite Delivery Contract Awarded Last action

Contract number
75N94018D00003
Awardee
Awarding agency
Task orders
18 $89,834,319 obligated

Award facts

Opportunity
  • NIHNICHDOPPTB20182 Solicitation number
Combined order value
  • $89,834,319 Current, with exercised options
  • $91,433,440 Potential, with all options
Last date to order 100% complete
IDV ceiling 94% used
$96,000,000.00
Award type
Single award
Who can order
Only the awarding agency
Set-aside
No set-aside
Competition
Full and Open Competition · 2 offers Negotiated Proposal / Quote
Pricing
Cost No Fee
Legislative mandates

Award details come from SAM.gov/FPDS.

About this IDV

Written by GovTribe AI ·

This indefinite delivery contract, awarded by the National Institute of Child Health and Human Development (NICHD), a civilian agency, to Duke University, aims to support the Best Pharmaceuticals for Children Act - Pediatric Trials Network (BPCA-PTN) program. The $96,000,000 contract has an ultimate completion date of June 3, 2026 and does not utilize any set-aside designations.

Under this IDV, Duke University's Office of Research Administration Division is the prime contractor and will provide a range of clinical research, biomedical studies, and data management services to advance the goals of the BPCA-PTN program. The task orders awarded to date cover activities such as maintaining expert teams to develop and implement clinical protocols, conducting pharmacoepidemiological and pharmacokinetic research, closing out and disseminating BPCA program data, and supporting innovative trial designs and assay development for pediatric therapeutics. This contract demonstrates Duke University's extensive expertise in delivering a diverse array of services to federal agencies through both prime contracts and subcontracts.

Task orders

Task order Ordering agency Obligated Awarded
Nichd pediatric and maternal resource center: bridging pharmacology and the real world 75N94024F00001 National Institute of Child Health and Human Development (NIH) $6,270,739
Bpca innovative trial designs and assay developments in pediatric therapeutics 75N94023F00004 National Institute of Child Health and Human Development (NIH) $8,783,682
Task order 15: bpca concept development, investigator development, and clinical trial readiness support 75N94023F00002 National Institute of Child Health and Human Development (NIH) $2,096,012
Bpca data closeout dissemination and engagement 75N94023F00003 National Institute of Child Health and Human Development (NIH) $4,438,814
The purpose of this task order is to maintain centralized teams of experts who will develop and implement clinical… 75N94023F00001 National Institute of Child Health and Human Development (NIH) $3,385,660
The purpose of this task order is to identify the remaining gaps in off-label use in children and to design clinical… 75N94022F00002 National Institute of Child Health and Human Development (NIH) $5,759,708
The goal of this task order is to perform pharmacoepidemiology research and a PK, pharmacodynamic, pharmacogenomic… 75N94022F00001 National Institute of Child Health and Human Development (NIH) $1,457,295
Pharmaceuticals (PK) and safety of commonly used drugs in lactating women and breastfed infants (cuddle 2.0) network 75N94021F00003 National Institute of Child Health and Human Development (NIH) $3,938,833
"defining the safety and efficacy of posterior tibial nerve stimulation in children(positron-c)" 75N94021F00002 National Institute of Child Health and Human Development (NIH) $862,140
Bpca pharmacoepidemiology (real world data) studies 75N94021F00001 National Institute of Child Health and Human Development (NIH) $2,394,452
Pharmacokinetic and safety of antiretroviral and related drugs lactating women and breastfed infants study 75N94020F00002 National Institute of Child Health and Human Development (NIH) $685,624
2020.500-covid-19 - best pharmaceuticals for children act pediatric trials network - covid-19 studies 75N94020F00001 National Institute of Child Health and Human Development (NIH) $7,448,227
To provide a platform for the inclusion of patients with down syndrome into the pharmacology-based clinical trials. The… 75N94019F00126 National Institute of Child Health and Human Development (NIH) $6,796,098
To perform innovative trial designs with clinically relevant outcomes such as endpoints, biomarkers, and epidemiology… 75N94019F00125 National Institute of Child Health and Human Development (NIH) $10,583,491
Bpca concept development and clinical trial readiness support 75N94018F00003 National Institute of Child Health and Human Development (NIH) $4,707,148
Bpca data closeout & dissemination 75N94018F00004 National Institute of Child Health and Human Development (NIH) $5,256,221
Bpca pharmacology studies - period of performance: 9/14/18 - 9/13/22 75N94018F00002 National Institute of Child Health and Human Development (NIH) $9,772,723
Core function activities 75N94018F00001 National Institute of Child Health and Human Development (NIH) $5,197,453
Show all 18

Transactions

Action Obligated Date
Other Administrative Action P00008 · Nichd:r & d: best pharmaceuticals for children act IDIQ $0
Other Administrative Action P00007 $0
Other Administrative Action P00006 · Best pharmaceuticals for children act $0
Other Administrative Action P00005 $0
Other Administrative Action P00004 · To incorporate article h.37. HIV antiretroviral treatment trials and update far clause 52.204-24, representation regarding certain telecommunications and… $0
Other Administrative Action P00003 $0
Other Administrative Action P00002 $0
Other Administrative Action P00001 $0
Original award $0

Subawards

Subcontractor Amount Awarded
Opans LLC To provide a platform for the inclusion of patients with down syndrome into the pharmacology-based clinical trials. The goals are to recruit this patient… $572,325
ANN & Robert H Lurie Childrens Hospital Of Chicago Bpca data closeout dissemination and engagement dcri #8647 PTN2: task order_16_bpca data closeout and dissemination 2.0 $42,660
International Childrens Advisory Network Inc. The purpose of this task order is to maintain centralized teams of experts who will develop and implement clinical protocols (and all supporting documents… $40,000
Pennsylvania State University The purpose of this task order is to maintain centralized teams of experts who will develop and implement clinical protocols (and all supporting documents… $47,884
University Of Utah Task order 15: bpca concept development, investigator development, and clinical trial readiness support dcri #8646 PTN2: task order 15 bpca concept DEV and… $53,861
Texas Christian University The purpose of this task order is to maintain centralized teams of experts who will develop and implement clinical protocols (and all supporting documents… $66,602
University Of Utah Bpca data closeout dissemination and engagement dcri #8647 PTN2: task order_16_bpca data closeout and dissemination 2.0 $227,379
University Of North Carolina At Chapel Hill The purpose of this task order is to maintain centralized teams of experts who will develop and implement clinical protocols (and all supporting documents… $55,252
The Children's Hospital Of Philadelphia Pharmacokinetic and safety of antiretroviral and related drugs lactating women and breastfed infants study dcri #8130 PTN2 task order 8 HIV lactation $116,079
University Of Louisville The purpose of this task order is to maintain centralized teams of experts who will develop and implement clinical protocols (and all supporting documents… $50,188

Quick answers

Who was awarded contract 75N94018D00003?

75N94018D00003 was awarded to Duke University by National Institute of Child Health and Human Development (National Institutes of Health) on June 4, 2018.

How much is contract 75N94018D00003 worth?

Orders under 75N94018D00003 have obligated $89,834,319. Their combined potential value, with all options, is $91,433,440. 75N94018D00003's own ceiling is $96,000,000.

How many orders have been placed under contract 75N94018D00003?

18 orders have been placed under 75N94018D00003, the latest on September 23, 2024.

Who can order from contract 75N94018D00003?

75N94018D00003 is a single award indefinite delivery contract. Only the awarding agency can place orders on it.

Was contract 75N94018D00003 competed?

The extent of competition for 75N94018D00003 was full and open competition. The government received 2 offers.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV
Try for free Login